BackDaily Target 2X Long MRNA ETF Overview

Daily Target 2X Long MRNA ETF Current Cash

Daily Target 2X Long MRNA ETF's current cash is $19M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$19.20M
↑ 24.14% YoYΔ $3.73M vs prior year quarter

Peer trimmed avg / median

Loading

Daily Target 2X Long MRNA ETF Current Cash History

Loading

Daily Target 2X Long MRNA ETF vs. peers: Current Cash Comparison

Loading

Daily Target 2X Long MRNA ETF Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Daily Target 2X Long MRNA ETF (MRNX) FAQ

As of the most recent data (June 2016), MRNX shows a current cash of $19M. That compares with $15M in the prior-year period — up 24.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MRNX's current cash is now $19M (was $15M) — a 24.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Daily Target 2X Long MRNA ETF is outperforming or lagging.

Tracking MRNX's current cash over time shows whether Daily Target 2X Long MRNA ETF is scaling, shrinking, or reshaping that part of the business. The current reading is $19M That compares with $15M in the prior-year period — up 24.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Daily Target 2X Long MRNA ETF's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $19M) with ownership activity and broader fundamentals.